Antimalarial Efficacy of Hydroxyethylapoquinine (SN-119) and Its Derivatives
Open Access
- 1 February 2014
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (2) , 820-827
Abstract
Quinine and other cinchona-derived alkaloids, although recently supplanted by the artemisinins (ARTs), continue to be important for treatment of severe malaria. Quinine and quinidine have narrow therapeutic indices, and a safer quinine analog is desirable, particularly with the continued threat of antimalarial drug resistance. Hydroxyethylapoquinine (HEAQ), used at 8 g a day for dosing in humans in the 1930s and halving mortality from bacterial pneumonias, was shown to cure bird malaria in the 1940s and was also reported as treatment for human malaria cases. Here we describe synthesis of HEAQ and its novel stereoisomer hydroxyethylapoquinidine (HEAQD) along with two intermediates, hydroxyethylquinine (HEQ) and hydroxyethylquinidine (HEQD), and demonstrate comparable but elevated antimalarial 50% inhibitory concentrations (IC 50 ) of 100 to 200 nM against Plasmodium falciparum quinine-sensitive strain 3D7 (IC 50 , 56 nM). Only HEAQD demonstrated activity against quinine-tolerant P. falciparum strains Dd2 and INDO with IC 50 s of 300 to 700 nM. HEQD had activity only against Dd2 with an IC 50 of 313 nM. In the lethal mouse malaria model Plasmodium berghei ANKA, only HEQD had activity at 20 mg/kg of body weight comparable to that of the parent quinine or quinidine drugs measured by parasite inhibition and 30-day survival. In addition, HEQ, HEQD, and HEAQ (IC 50 ≥ 90 μM) have little to no human ether-à-go-go-related gene (hERG) channel inhibition expressed in CHO cells compared to HEAQD, quinine, and quinidine (hERG IC 50 s of 27, 42, and 4 μM, respectively). HEQD more closely resembled quinine in vitro and in vivo for Plasmodium inhibition and demonstrated little hERG channel inhibition, suggesting that further optimization and preclinical studies are warranted for this molecule.Keywords
This publication has 37 references indexed in Scilit:
- Investigating the activity of quinine analogues versus chloroquine resistant Plasmodium falciparumBioorganic & Medicinal Chemistry, 2012
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumCurrent Opinion in Infectious Diseases, 2011
- Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular dataMalaria Journal, 2011
- A single, low, oral dose of a 5-carbon-linked trioxane dimer orthoester plus mefloquine cures malaria-infected miceBioorganic & Medicinal Chemistry Letters, 2011
- Profiling Diverse Compounds by Flux- and Electrophysiology-Based Primary Screens for Inhibition of Human Ether-à-go-go Related Gene Potassium ChannelsASSAY and Drug Development Technologies, 2010
- Chemical genetics of Plasmodium falciparumNature, 2010
- Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug ScreeningAntimicrobial Agents and Chemotherapy, 2007
- The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallizationBiochemical Journal, 2007
- Prevalence of In Vitro Resistance to Eleven Standard or New Antimalarial Drugs among Plasmodium falciparum Isolates from Pointe-Noire, Republic of the CongoJournal of Clinical Microbiology, 2006